Post-chemo-radiotherapy response and pseudo-progression evaluation on glioma cell types by multi-parametric magnetic resonance imaging: a prospective study

Early Detection of Radiation-Induced Injury and Prediction of Cognitive Deficit by MRS Metabolites in Radiotherapy of Low-Grade Glioma

(2021) Zahra Alirezaei et al.   Biomed Research International

Reliability of Magnetic Resonance Spectroscopy and Positron Emission Tomography Computed Tomography in Differentiating Metastatic Brain Tumor Recurrence from Radiation Necrosis

(2021) Sarah Travers et al.   World Neurosurgery

Distinguishing Tumor Recurrence From Radiation Necrosis in Treated Glioblastoma Using Multiparametric MRI

(2021) Aozi Feng et al.   ACADEMIC RADIOLOGY

Advanced ADC Histogram, Perfusion, and Permeability Metrics Show an Association with Survival and Pseudoprogression in Newly Diagnosed Diffuse Intrinsic Pontine Glioma: A Report from the Pediatric Brain Tumor Consortium

(2020) S. Vajapeyam et al.   AMERICAN JOURNAL OF NEURORADIOLOGY

Combined application of MRS and DWI can effectively predict cell proliferation and assess the grade of glioma: A prospective study

(2020) Xvlei Hu et al.   JOURNAL OF CLINICAL NEUROSCIENCE

Early Response Assessment of Glioma Patients to Definitive Chemoradiotherapy Using Chemical Exchange Saturation Transfer Imaging at 7 T

(2019) Jan-Eric Meissner et al.   JOURNAL OF MAGNETIC RESONANCE IMAGING

Diagnostic performance of multiparametric MRI in the evaluation of treatment response in glioma patients at 3T

(2019) Jie Liu et al.   JOURNAL OF MAGNETIC RESONANCE IMAGING

Response Assessment in Neuro-Oncology Criteria for Gliomas: Practical Approach Using Conventional and Advanced Techniques

(2019) D.J. Leao et al.   AMERICAN JOURNAL OF NEURORADIOLOGY

Clinical significance of the 2016 WHO classification in Japanese patients with gliomas

(2018) Toshihiko Iuchi et al.   Brain Tumor Pathology

The diagnostic value of using combined MR diffusion tensor imaging parameters to differentiate between low- and high-grade meningioma

(2018) Kerim Aslan et al.   BRITISH JOURNAL OF RADIOLOGY

Quantitative magnetic resonance imaging and radiogenomic biomarkers for glioma characterisation: a systematic review

(2018) Pohchoo Seow et al.   BRITISH JOURNAL OF RADIOLOGY

Radiation Necrosis, Pseudoprogression, Pseudoresponse, and Tumor Recurrence: Imaging Challenges for the Evaluation of Treated Gliomas

(2018) Anastasia Zikou et al.   Contrast Media & Molecular Imaging

Three-dimensional echo planar spectroscopic imaging for differentiation of true progression from pseudoprogression in patients with glioblastoma

(2018) Gaurav Verma et al.   NMR IN BIOMEDICINE

Response Assessment in Neuro-Oncology Clinical Trials

(2017) Patrick Y. Wen et al.   JOURNAL OF CLINICAL ONCOLOGY

European Association for Neuro-Oncology (EANO) guideline on the diagnosis and treatment of adult astrocytic and oligodendroglial gliomas

(2017) Michael Weller et al.   LANCET ONCOLOGY

Incidence of Tumour Progression and Pseudoprogression in High-Grade Gliomas: a Systematic Review and Meta-Analysis

(2017) Abdul W. Abbasi et al.   Clinical Neuroradiology

Incidence of pseudoprogression in low-grade gliomas treated with radiotherapy

(2016) Sophie E. van West et al.   NEURO-ONCOLOGY

Parametric Response Mapping of Apparent Diffusion Coefficient as an Imaging Biomarker to Distinguish Pseudoprogression from True Tumor Progression in Peptide-Based Vaccine Therapy for Pediatric Diffuse Intrinsic Pontine Glioma

(2015) R. Ceschin et al.   AMERICAN JOURNAL OF NEURORADIOLOGY

Diffusion and Perfusion MRI to Differentiate Treatment-Related Changes Including Pseudoprogression from Recurrent Tumors in High-Grade Gliomas with Histopathologic Evidence

(2015) A.J. Prager et al.   AMERICAN JOURNAL OF NEURORADIOLOGY

Comparison between magnetic resonance spectroscopy and diffusion weighted imaging in the evaluation of gliomas response after treatment

(2015) Antonella Lotumolo et al.   EUROPEAN JOURNAL OF RADIOLOGY

Characterization of pseudoprogression in patients with glioblastoma: is histology the gold standard?

(2015) Isaac Melguizo-Gavilanes et al.   JOURNAL OF NEURO-ONCOLOGY

The Diagnostic Ability of Follow-Up Imaging Biomarkers after Treatment of Glioblastoma in the Temozolomide Era: Implications from Proton MR Spectroscopy and Apparent Diffusion Coefficient Mapping

(2015) Martin Bulik et al.   Biomed Research International

Toward Distinguishing Recurrent Tumor From Radiation Necrosis: DWI and MTC in a Gamma Knife–Irradiated Mouse Glioma Model

(2014) Carlos J. Perez-Torres et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

A GEE approach to determine sample size for pre- and post-intervention experiments with dropout

(2013) Song Zhang et al.   COMPUTATIONAL STATISTICS & DATA ANALYSIS

Differentiation of True Progression from Pseudoprogression in Glioblastoma Treated with Radiation Therapy and Concomitant Temozolomide: Comparison Study of Standard and High-b-Value Diffusion-weighted Imaging

(2013) Hee Ho Chu et al.   RADIOLOGY

Diffusion-weighted MR Imaging for the Differentiation of True Progression from Pseudoprogression Following Concomitant Radiotherapy with Temozolomide in Patients with Newly Diagnosed High-grade Gliomas

(2012) Woong Jae Lee et al.   ACADEMIC RADIOLOGY

Treatment Monitoring in Gliomas

(2011) Jonathan Vöglein et al.   INVESTIGATIVE RADIOLOGY

Clinical trial end points for high-grade glioma: the evolving landscape

(2011) D. A. Reardon et al.   NEURO-ONCOLOGY

Updated Response Assessment Criteria for High-Grade Gliomas: Response Assessment in Neuro-Oncology Working Group

(2010) Patrick Y. Wen et al.   JOURNAL OF CLINICAL ONCOLOGY

Evaluation of diffusion parameters as early biomarkers of disease progression in glioblastoma multiforme

(2010) I. S. Khayal et al.   NEURO-ONCOLOGY